(Abst.) DMTs and time to loss of ambulatory function in PwPPMS on: September 06, 2022, 04:01:38 pm #1 From JAMA Neurology (July 25, 2022)--"Disease-modifying treatments and time to loss of ambulatory function in patients with primary progressive multiple sclerosis":https://jamanetwork.com/journals/jamaneurology/article-abstract/2794292 Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
